K Number
K121832
Device Name
RESOLVE BILIARY LOCKING DRAINAGE CATHETER
Date Cleared
2012-07-17

(25 days)

Product Code
Regulation Number
876.5010
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The ReSolve® Biliary Locking Drainage Catheter with locking pigtail and hydrophilic coating is used for drainage of bile within the biliary system.
Device Description
The ReSolve® Biliary Locking Drainage Catheter consists of single lumen tubing with two suture holes and 17 to 18 drainage holes in the distal curve region. It is made from a biocompatible thermoplastic. A hydrophilic coating reduces entry site/catheter friction during placement. The components of the catheter allow initial placement using an over-the-wire technique. These include a metal stiffening cannula, flexible stiffening cannula, straightener, and repositioning tool. The pigtail straightener is provided to assist in feeding the guide wire through the catheter. Once the catheter position is established in the area to be drained, the pigtail is formed by retracting a suture which is looped from the hub, to the catheter tip and back to the hub. The hub incorporates a suture locking mechanism to retain the distal pigtail shape. It may be unlocked using the repositioning tool to allow repositioning or replacement of the catheter. A single radiopaque marker band is located proximal to the most proximal drainage hole to assist in accurate placement of the drainage holes in the biliary duct.
More Information

Not Found

No
The device description focuses on the mechanical components and function of a drainage catheter, with no mention of software, algorithms, or data processing that would indicate AI/ML.

Yes
The device is used for "drainage of bile within the biliary system," which is a physiological process aimed at restoring or maintaining normal bodily function, thus qualifying it as therapeutic.

No

This device is used for drainage of bile, which is a therapeutic function, not a diagnostic one. It helps manage a condition rather than identify or characterize it.

No

The device description clearly outlines physical components made from biocompatible thermoplastic, including tubing, suture holes, drainage holes, a metal stiffening cannula, flexible stiffening cannula, straightener, repositioning tool, and a hub with a suture locking mechanism. This indicates a hardware-based medical device, not a software-only one.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens, including blood and tissue samples, derived from the human body, solely or principally for the purpose of providing information concerning a physiological state, state of health, or disease or congenital abnormality.
  • Device Function: The ReSolve® Biliary Locking Drainage Catheter is a device that is inserted into the body (specifically the biliary system) to drain bile. It is a therapeutic device used for a physical intervention.
  • Lack of Specimen Examination: The description does not mention the device being used to examine any specimens from the body. Its purpose is drainage, not analysis of biological samples.

Therefore, the function and intended use of this device clearly fall outside the definition of an In Vitro Diagnostic.

N/A

Intended Use / Indications for Use

The ReSolve® Biliary Locking Drainage Catheter with locking pigtail and hydrophilic coating is used for drainage of bile within the biliary system.

Product codes (comma separated list FDA assigned to the subject device)

FGE

Device Description

The ReSolve® Biliary Locking Drainage Catheter consists of single lumen tubing with two suture holes and 17 to 18 drainage holes in the distal curve region. It is made from a biocompatible thermoplastic. A hydrophilic coating reduces entry site/catheter friction during placement. The components of the catheter allow initial placement using an over-the-wire technique. These include a metal stiffening cannula, flexible stiffening cannula, straightener, and repositioning tool. The pigtail straightener is provided to assist in feeding the guide wire through the catheter. Once the catheter position is established in the area to be drained, the pigtail is formed by retracting a suture which is looped from the hub, to the catheter tip and back to the hub. The hub incorporates a suture locking mechanism to retain the distal pigtail shape. It may be unlocked using the repositioning tool to allow repositioning or replacement of the catheter. A single radiopaque marker band is located proximal to the most proximal drainage hole to assist in accurate placement of the drainage holes in the biliary duct.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

biliary system

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Prescription Use

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance testing of the ReSolve Biliary Locking Drainage Catheter was conducted based on a risk analysis and based on the requirements of the following international standards:

  • ISO 11135-1:2007, Sterilization of health care products -. Ethylene oxide - Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
  • ISO 10993-1:2009, Biological Evaluation of Medical Devices ● Part-1: Evaluation and Testing within a risk management process, and the FDA Modified ISO 10993 Test Profile
  • ISO 10993-5:2009. Biological evaluation of medical devices -. Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-7:2008, Biological Evaluation of Medical Devices -. Part 7: Ethylene Oxide Sterilization Residuals
  • ISO 10993-10:2010. Biological evaluation of medical devices -Part 10: Tests for irritation and skin sensitization
  • ISO 10993-11:2006, Biological evaluation of medical devices -. Part 11: Tests for systemic toxicity
  • ISO 10993-17:2002, Biological Evaluation of Medical Devices -. Part 17: Methods for the Establishment of Allowable Limits for Leachable Substances
  • ISO 10993-18:2005, Biological Evaluation of Medical Devices - Part 18: Chemical Characterization of Materials
  • USP 34 :2011, United States Pharmacopeia 34, National ● Formulary 29, 2011. Pyrogen Test.
  • EN 1617:1997, Sterile Drainage Catheters and Accessory . Devices for Single Use
  • ASTM D4169-09:2009, Standard Practice for Performance . Testing of Shipping Containers and Systems
  • ASTM F 1980-07:2007, Standard Guide for Accelerated Aging ● of Sterile Barrier Systems for Medical Devices
  • ISO 2233:2000, Packaging Complete, Filled Transport . Packages and Unit Loads - Conditioning for Testing

The following is a list of all significant testing that was successfully completed:
Design Verification
Conditioning
Dimensional
Drainage Hole Orientation
Marker Band/Hole Location
Tip Penetration
Hub Leak
Vacuum Test
Tubing Kink Test
Marker Band Adhesion
Hub Tensile Testing
Tubing Tensile Testing
Material Durability Testing
Bile Exposure Testing
Stiffening Cannula Friction Test
Biocompatibility Tests
Cytotoxicity
Irritation
Acute Systemic Toxicity
Pvrogenicitv
Chemical Characterization

The results of the testing demonstrated that the subject ReSolve Biliary Locking Drainage Catheter met the pre-determined acceptance criteria applicable to the safety and efficacy of the device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K063733

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 876.5010 Biliary catheter and accessories.

(a)
Identification. A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap.(b)
Classification. Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

0

ReSolve® Biliary Locking Drainage Catheter
Section 5, 510(k) Summary Special Premarket Notification 510(k)

·

:

.

·

·

PAGE 1 OF 4

K121832

: ﯔ ﺭەﻳﻖ ﺋﺎﺭﯨﺪﯨﻦ ﺑﻮﻟﯘﭖ ﺗﺎﺭﯨﺨﻰ ﺑﯩﺮ ﻗﺎﺭﯨﺪﯨﻐﺎ

Section 5JUL 17
510(k) Summary
General
ProvisionsSubmitter Name:
Address:
Telephone Number:
Fax Number:
Contact Person:
Date of Preparation:
Registration Number:Merit Medical Systems, Inc.
1600 West Merit Parkway
South Jordan, UT 84095
(801) 316-4932
(801) 316-4860
Casey Hughes
06/18/2012
1721504
Subject
DeviceTrade Name:
Common/Usual Name:
Classification Name:ReSolve® Biliary Locking Drainage Catheter
Biliary Drainage Catheter
Catheter, Biliary, Diagnostic
Predicate
DeviceTrade Name:
Common/Usual Name:
Classification Name:
Premarket Notification:
Manufacturer:ReSolve® Biliary Drainage Catheter
Biliary Drainage Catheter
Catheter, Biliary, Diagnostic
K063733
Merit Medical Systems, Inc.
ClassificationClass II
21 CFR § 876.5010
Gastroenterology/Urology
Intended UseThe ReSolve® Biliary Locking Drainage Catheter with locking pigtail
and hydrophilic coating is used for drainage of bile within the biliary
system.

్ట్రీ మా

1

ReSolve® Biliary Locking Drainage Catheter Section 5, 510(k) Summary Special Premarket Notification 510(k)

Device Description The ReSolve® Biliary Locking Drainage Catheter consists of single lumen tubing with two suture holes and 17 to 18 drainage holes in the distal curve region. It is made from a biocompatible thermoplastic. A hydrophilic coating reduces entry site/catheter friction during placement. The components of the catheter allow initial placement using an over-the-wire technique. These include a metal stiffening cannula, flexible stiffening cannula, straightener, and repositioning tool. The pigtail straightener is provided to assist in feeding the guide wire through the catheter. Once the catheter position is established in the area to be drained, the pigtail is formed by retracting a suture which is looped from the hub, to the catheter tip and back to the hub. The hub incorporates a suture locking mechanism to retain the distal pigtail shape. It may be unlocked using the repositioning tool to allow repositioning or replacement of the catheter. A single radiopaque marker band is located proximal to the most proximal drainage hole to assist in accurate placement of the drainage holes in the biliary duct.

Technological Characteristics

The technological characteristics of the subject ReSolve Biliary Locking Drainage Catheter are substantially equivalent to those of the predicate device, the ReSolve Biliary Drainage Catheter, 510(k) K063733.

2

K121832
PAGE 3 OF 4

No performance standards have been established under Section 514 of the Food, Drug and Cosmetic Act for these devices. Performance testing of the ReSolve Biliary Locking Drainage Catheter was conducted based on a risk analysis and based on the requirements of the following international standards:

  • ISO 11135-1:2007, Sterilization of health care products -. Ethylene oxide - Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
  • ISO 10993-1:2009, Biological Evaluation of Medical Devices ● Part-1: Evaluation and Testing within a risk management process, and the FDA Modified ISO 10993 Test Profile
  • ISO 10993-5:2009. Biological evaluation of medical devices -. Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-7:2008, Biological Evaluation of Medical Devices -. Part 7: Ethylene Oxide Sterilization Residuals
  • ISO 10993-10:2010. Biological evaluation of medical devices -Part 10: Tests for irritation and skin sensitization

Safety & Performance Tests

  • ISO 10993-11:2006, Biological evaluation of medical devices -. Part 11: Tests for systemic toxicity
  • ISO 10993-17:2002, Biological Evaluation of Medical Devices -. Part 17: Methods for the Establishment of Allowable Limits for Leachable Substances
  • ISO 10993-18:2005, Biological Evaluation of Medical Devices -� Part 18: Chemical Characterization of Materials
  • USP 34 :2011, United States Pharmacopeia 34, National ● Formulary 29, 2011. Pyrogen Test.
  • EN 1617:1997, Sterile Drainage Catheters and Accessory . Devices for Single Use
  • ASTM D4169-09:2009, Standard Practice for Performance . Testing of Shipping Containers and Systems
  • ASTM F 1980-07:2007, Standard Guide for Accelerated Aging ● of Sterile Barrier Systems for Medical Devices
  • ISO 2233:2000, Packaging Complete, Filled Transport . Packages and Unit Loads - Conditioning for Testing

The following is a list of all significant testing that was successfully completed:

3

ReSolve® Biliary Locking Drainage Catheter Section 5, 510(k) Summary Special Premarket Notification 510(k)

Design Verification Conditioning Dimensional Drainage Hole Orientation Marker Band/Hole Location Tip Penetration Hub Leak Vacuum Test Tubing Kink Test Safety & Marker Band Adhesion Performance Hub Tensile Testing Tests cont. Tubing Tensile Testing Material Durability Testing Bile Exposure Testing Stiffening Cannula Friction Test Biocompatibility Tests Cytotoxicity Irritation Acute Systemic Toxicity Pvrogenicitv Chemical Characterization Safety & The results of the testing demonstrated that the subject ReSolve Performance Biliary Locking Drainage Catheter met the pre-determined acceptance criteria applicable to the safety and efficacy of the Tests cont. device. Based on the indications for use, design, and safety and performance testing, the subject ReSolve Biliary Locking Drainage Summary of Catheter meets the requirements that are considered essential for Substantial its intended use and is substantially equivalent to the predicate Equivalence device, the ReSolve Biliary Drainage Catheter, manufactured by

Merit Medical Systems. Inc.

4

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three tail feathers, representing the department's mission to protect the health of all Americans and provide essential human services. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular fashion around the eagle.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room-WO66-G609 Silver Spring, MD 20993-0002

Ms. Casey Hughes Manager, Regulatory Affairs Merit Medical Systems, Inc. 1600 West Merit Parkway SOUTH JORDAN UT 84095

JUL 1 7 2012

K121832 Re:

Trade/Device Name: Resolve® Biliary Locking Drainage Catheter Regulation Number: 21 CFR§ 876.5010 Regulation Name: Biliary catheter and accessories Regulatory Class: II Product Code: FGE Dated: June 18, 2012 Received: June 22, 2012

Dear Ms. Hughes:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. However, you are responsible to determine that the medical devices you use as components in the kit have either been determined as substantially equivalent under the premarket notification process (Section 510(k) of the act), or were legally on the market prior to May 28, 1976, the enactment date of the Medical Device Amendments. Please note: If you purchase your device components in bulk (i.e., unfinished) and further process (e.g., sterilize) you must submit a new 510(k) before including these components in your kit. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

5

Page 2 - Ms.Casey Hughes

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely vours.

Hubert Demerino

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

6

ReSolve® Biliary Locking Drainage Catheter Section 4, Indications for Use Special Premarket Notification 510(k)

Section 4

Indications for Use

K121832

510(k) Number (if known):

Device Name: ReSolve® Biliary Locking Drainage Catheter

Indications for Use:

The ReSolve® Biliary Locking Drainage Catheter with locking pigtail and hydrophilic coating is used for drainage of bile within the biliary system.

Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Hulut Leen

Division Sign-Off) Division of Reproductive, Gastro-Renal, and Jrological Devices 121832 510(k) Number